Cadrenal Therapeutics, Inc. Common Stock (CVKD) vs Revelation Biosciences, Inc. (REVB)

A side-by-side comparison of Cadrenal Therapeutics, Inc. Common Stock and Revelation Biosciences, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Cadrenal Therapeutics, Inc. Common Stock logo
CVKD
Cadrenal Therapeutics, Inc. Common Stock
$3M
$0.92HealthcareDelayed quote: Oct 6, 2026, 12:58 PM EDT
Revelation Biosciences, Inc. logo
REVB
Revelation Biosciences, Inc.
$3M
$0.80HealthcareDelayed quote: Oct 6, 2026, 12:45 PM EDT

Total return — CVKD vs REVB

growth of $100 · dividends reinvested · last 4y
CVKD -98.5% (-64.8%/yr)REVB -100.0% (-93.7%/yr)CVKD compounded faster over this window
Log scale — wide-divergence pair
0001101001kStart $100202420252026$2$0
CVKD REVB

CVKD vs REVB: by the numbers

  • •CVKD is the larger company ($3M vs $3M market cap).

Metrics side by side

Valuation

MetricCVKDREVB
P/B ratio0.800.31

Profitability

MetricCVKDREVB
Gross margin0.00%0.00%
Operating margin0.00%0.00%
Net margin0.00%0.00%
ROE-282.13%-106.79%
ROIC-284.81%-104.28%

Growth (annualized)

MetricCVKDREVB
Total return CAGR (5Y)N/A-93.52%

Go deeper

Full CVKD analysisFull REVB analysisInteractive comparison tool

Dig into the metrics

Cadrenal Therapeutics, Inc. Common Stock ROERevelation Biosciences ROECadrenal Therapeutics, Inc. Common Stock operating marginRevelation Biosciences operating marginCadrenal Therapeutics, Inc. Common Stock revenue growthRevelation Biosciences revenue growthCadrenal Therapeutics, Inc. Common Stock free cash flowRevelation Biosciences free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.